Ralf Bergmann

Professor

Semmelweis University

Hungary

Research Interests

Explore related searches

Professors in Hungary Professors in Immunology Immunology professors in Hungary

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Ralf Bergmann is a faculty member at Semmelweis University, Hungary. His research areas focus on innovative cancer therapies, including the development of novel immunotherapeutic strategies and radioimmunotherapy. His recent publications encompass topics such as tree sap flow theories, in vivo imaging studies with radiolabeled platelets, and the characterization of antibody-based treatments for prostate cancer and leukemia.

Articles (12)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Antje Dietrich

GERMANY

View details

Jens Pietzsch

Member of Faculty; Professor of Pathobiochemistry/Medicinal Biochemistry

Technische Universität Dresden

GERMANY

View details

Tibor Kovács

University of Pannonia

HUNGARY

View details

Zoltán Benyó

Semmelweis University

HUNGARY

View details

Domokos Máthé

Head

HUNGARY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ralf Bergmann

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

A new theory of tree sap flow

Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5

Radiolabeling of Platelets with <sup>99m</sup>Tc-HYNIC-Duramycin for In Vivo Imaging Studies

Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells

Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)

Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management

Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial

Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy

And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling

Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner

Suppression of Metastatic Melanoma Growth in Lung by Modulated Electro-Hyperthermia Monitored by a Minimally Invasive Heat Stress Testing Approach in Mice

Telemedicine Pre and Post Covid-19: Lessons for Commercialisation Based on Previous Use Cases

Collaborators (5)

Antje Dietrich

Jens Pietzsch

Tibor Kovács

Zoltán Benyó

Domokos Máthé

Make your next move.